Golden has been acquired by ComplyAdvantage.Read about it here ⟶

Oerth Bio

Oerth Bio is a Durham, North Carolina-based company founded by John W. Dombrosky.

Overview Structured Data Issues Contributors Activity

All edits

Edits on 6 Sep, 2023

"prospector:3163:3600603"

Katrina-Kay Pettitt

edited on 6 Sep, 2023

Edits made to:

Infobox (+1/-1 properties)

Infobox

Number of Employees (Ranges)

5 – 9

Number of Employees (Ranges)

1 – 4

Edits on 17 Mar, 2023

"prospector:2473:2564507"

Katrina-Kay Pettitt

edited on 17 Mar, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Industry

Biotechnology

Edits on 16 Mar, 2023

"prospector:2472:2549416"

Katrina-Kay Pettitt

edited on 16 Mar, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Industry

Biology

Edits on 23 Feb, 2023

"prospector:2317:2480892"

Katrina-Kay Pettitt

edited on 23 Feb, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Industry

Technology

Edits on 29 Jul, 2022

Andrey Duzenko

edited on 29 Jul, 2022

Edits made to:

Infobox (+6 properties)

Infobox

CEO

John W. Dombrosky

Full address

112 South Duke Street, Suite 1 Durham, North Carolina 27701 United States0

Location

Durham, North Carolina

COO

Country

CTO

Email address

bd@oerthbio.com0

careers@oerthbio.com0

pr@oerthbio.com0

Edits on 28 Jul, 2022

"remove blacklisted domain URLs"

Golden AI

edited on 28 Jul, 2022

Edits made to:

Article

Article

Oerth Bio is a developer of targeted protein degraders for agricultural applications. The company leverages Arvinas' novel PROTAC protein degrader technology to develop human therapeutics for patients with cardiovascular, oncological, and gynecological diseases.

Edits on 16 May, 2022

"prospector:1525:717622"

Katrina-Kay Pettitt

edited on 16 May, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Is a

Organization

Edits on 1 Nov, 2021

"Inferring industry - ai.social_media_extractor.01"

Golden AI

edited on 1 Nov, 2021

Edits made to:

Infobox (+1/-1 properties)

Infobox

Twitter

https://twitter.com/oerthbio

Twitter

https://twitter.com/OerthBio

Edits on 13 May, 2021

Amit Gehlot

edited on 13 May, 2021

Edits made to:

Infobox (+2 properties)

Infobox

B2X

B2B

Pitchbook

https://pitchbook.com/profiles/company/267971-59

Edits on 12 May, 2021

"Funding autocalculation"

Golden AI

edited on 12 May, 2021

Edits made to:

Infobox (+1 properties)

Infobox

Latest funding type

‌

Corporate funding round

Edits on 29 Apr, 2021

Bhupendra Solanki

edited on 29 Apr, 2021

Edits made to:

Infobox (+1 properties)

Infobox

Full address

112 South Duke Street, Suite 1 Durham, North Carolina 27701 United States

Edits on 17 Apr, 2021

"Funding autocalculation"

Golden AI

edited on 17 Apr, 2021

Edits made to:

Infobox (+2 properties)

Infobox

Latest funding round date

February 2020

Total funding amount (USD)

55,000,000

"Found on funding round"

Golden AI

edited on 17 Apr, 2021

Edits made to:

Infobox (+2 properties)

Infobox

Investors

Bayer

Arvinas

Golden AI

edited on 17 Apr, 2021

Edits made to:

Infobox (+1 properties)

Infobox

Funding rounds

‌

Oerth Bio Corporate funding round, February 2020

Edits on 14 Apr, 2021

"prospector:192:99614"

Golden AI

edited on 14 Apr, 2021

Edits made to:

Infobox (+1 properties)

Infobox

Company status

Active

Edits on 2 Apr, 2021

Jude Gomila

approved a suggestion from Golden's AI on 2 Apr, 2021

Edits made to:

Article (+7/-7 characters)

Article

Oerth Bio is a developer of targeted protein degraders for agricultural applications. The company leverages ArvinasArvinas' novel PROTAC protein degrader technology to develop human therapeutics for patients with cardiovascular, oncological, and gynecological diseases.

Edits on 31 Mar, 2021